We have successfully registered AMR clubs in 15 universities across the country with few more in the process. We are building a consortium of youths, to take charge in #AMR awareness and education. Be a part of this movement, join our #AMR clubs today.

Youth engagement is intrinsic to global #AMR action

Find out more about the youth manifesto for the UNGA High level meeting & join #youngpeople to prevent #AMR
🦠 💊 🦠

bit.ly/3QPJiDK

Thank you Superbugs 🦠🔬🏫🧒🏽
We are stronger together.

PSN Enugu State and #Nemel pharmaceuticals makers of #Tensivin and #Cotripin celebrates #WorldHypertensionDay

📢 Young people play an important role in promoting peace on the continent!

Apply to join the 1st Cohort of the Network of African Youth in Conflict Prevention & Mediation (Wise Youth Network)
Application 🔗: t.ly/Xu_No

Deadline: June 14th, 2024
African Union

From AiS Archive 👇🏽
Preprints in Scholarly Publishing: Opportunities and Concerns
Dr Oya Y. Rieger, Ph.D. Oya Y Rieger is a Senior Strategist, Ithaka S+R Ithaka S+R, ITHAKA, New York, USA.
Watch Dr Rieger’s AiS Lecture👉🏽 youtu.be/79ji-u9KgYU?si…
#Preprints #Africa

Super proud!!! 👏😍

Now we get to see AMR Clubs in Nigerian universities. It's so exciting!

One of the greatest achievements in the fight against AMR would be the implementation of the recommendations outlined in the GLG report:  Towards specific commitments and action in the response to antimicrobial resistance: amrleaders.org/resources/m/it…

Like any other drug, vaccines have side mild effects that resolve only sholtly. Ask your #Pharmacist how to manage such side effects for your comfort post-immunization. Do not fear!

#HumanlyPossible : Immunization for All

Daniel Waruingi
Jimmy Nkaiwuatei

Let us eradicate #polio together
It is #HumanlyPossible , we did it on small pox

Jimmy Nkaiwuatei
Daniel Waruingi

Pediatrics are one the most vulnerable populations to antimicrobial-resistant infections.
R&D of new therapeutics and the optimization of the existing medicines will help to alleviate AMR among these critical populations.

Immunization is one of human health's greatest achievements of the 20th century.

This has enabled the eradication of highly deadly infections such as smallpox, polio & many more, thus saving lives and ensuring human survival.

Students Against Superbugs Africa
Gathai Mundia
Daniel Waruingi

Nurturing future Leaders against the global health threat of #AMR .

Good work Kenneth Egwu

As the population of primates and rodents declines, it is empirical to shift the focus toward new approach methodologies (NAMS) such as computational modeling to avoid over-reliance on these animals in medical research.

factor.niehs.nih.gov/2024/3/science…

KCU AMR club leaders happen to be attending the national AMR leaders workshop at kabale university, thanks to #wave , #ReActAfrica_RAN , among others behind such initiative towards combating this silent pandemic #AMR . Hope it will be be so impactful in this move!

Out now👇.

The alternative medicines for the management and treatment of both infectious/communicable and non-communicable diseases in Africa and beyond.

Africa in Science

I am extremely excited about this remarkable achievement by the team I am part of.

I must applaud the efforts of the very dedicated team of #AMR #Champions at the University of Ilorin, University of Ilorin, Nigeria .

Kenneth Egwu
Ibrahim Adamu Ingawa
AMR Intervarsity Training Program

𝐌𝐢𝐧𝐢𝐬𝐭𝐫𝐲 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡 𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐞𝐬 𝐒𝐮𝐫𝐠𝐞 𝐢𝐧 𝐑𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐈𝐥𝐥𝐧𝐞𝐬𝐬𝐞𝐬: 𝐃𝐫. 𝐏𝐚𝐭𝐫𝐢𝐜𝐤 𝐀𝐦𝐨𝐭𝐡 𝐔𝐫𝐠𝐞𝐬 𝐏𝐮𝐛𝐥𝐢𝐜 𝐕𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞

The Ministry of Health has responded to a recent increase in respiratory infections,

COMING SOON…
Alternative Medicine for Africa
AiS BiteSize video by Hlapisi Nthabeleng, MSc. Nthabeleng Hlapisi, PhD Candidate at the University of KwaZulu Natal, South Africa.
#AlternativeMedicine #Science #Africa

The AI drug discovery era has arrived. The Economist delves into the substantial momentum happening in the industry which has consolidated around a few key players & how Insilico is playing a leading role w/ an #AI drug for #IPF in Phase II trials. economist.com/technology-qua…